Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greenbaum

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Diabetes|August 29, 2006
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled studyVicki Seyfert-Margolis, Trang D Gisler, Adam L Asare, et al.
Diabetes Care|September 26, 2015
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportDiane K Wherrett, Jane L Chiang, Alan M Delamater, et al.
Diabetes Care|September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to PreventionEmily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2013
Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in YouthCatherine Pihoker, Lisa K Gilliam, Sian Ellard, et al.
Diabetes Care|March 6, 2020
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
JCI Insight|October 25, 2022
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell functionCate Speake, Tania Habib, Katharina Lambert, et al.
Diabetes|June 7, 2019
Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 DiabetesMaria J Acevedo-Calado, Susan L Pietropaolo, Michael P Morran, et al.
Diabetes Care|September 13, 2013
B-lymphocyte depletion with rituximab and β-cell function: two-year resultsMark D Pescovitz, Carla J Greenbaum, Brian Bundy, et al.
Diabetes Care|December 19, 2014
Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetesAsa K Davis, Stephanie N DuBose, Michael J Haller, et al.
The Journal of Clinical Investigation|December 10, 2019
Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progressionAlice E Wiedeman, Virginia S Muir, Mario G Rosasco, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Diabetes|August 29, 2006
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled studyVicki Seyfert-Margolis, Trang D Gisler, Adam L Asare, et al.
Diabetes Care|September 26, 2015
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportDiane K Wherrett, Jane L Chiang, Alan M Delamater, et al.
Diabetes Care|September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to PreventionEmily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2013
Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in YouthCatherine Pihoker, Lisa K Gilliam, Sian Ellard, et al.
Diabetes Care|March 6, 2020
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
JCI Insight|October 25, 2022
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell functionCate Speake, Tania Habib, Katharina Lambert, et al.
Diabetes|June 7, 2019
Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 DiabetesMaria J Acevedo-Calado, Susan L Pietropaolo, Michael P Morran, et al.
Diabetes Care|September 13, 2013
B-lymphocyte depletion with rituximab and β-cell function: two-year resultsMark D Pescovitz, Carla J Greenbaum, Brian Bundy, et al.
Diabetes Care|December 19, 2014
Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetesAsa K Davis, Stephanie N DuBose, Michael J Haller, et al.
The Journal of Clinical Investigation|December 10, 2019
Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progressionAlice E Wiedeman, Virginia S Muir, Mario G Rosasco, et al.
Pageof 23